All NewsBio/Pharma News
All PublicationsPharmTechPharmTech Europe
MarketplaceICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksWhitepapers
Webcasts
All VideosAsk the ExpertBehind The HeadlinesBuy, Sell, HoldDrug Digest VideosDrug Solutions PodcastPeer ExchangeSexy ScienceTech Talk
Conference CoverageConference ListingEvents
Subscribe
AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
Spotlight -
  • Analytics
  • Dosage Forms
  • Drug Development
  • Manufacturing
  • Outsourcing
  • Quality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

    • Webcasts
    • Subscribe
Advertisement

News

Article

PTSM: Pharmaceutical Technology Sourcing and Management

August 4, 2014

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management-08-06-2014
Volume10
Issue 8

Metrics Contract Services Adopts New Name and Logo

Author(s):

Pharmaceutical Technology Editors

Metrics Contract Services adopts a more descriptive name and brand that identifies it as being part of the Mayne Pharma global family.

Metrics Contract Services, a contract pharmaceutical formulation development and manufacturing organization, has adopted a new and more descriptive name.

The company is unveiling a new brand look that more clearly identifies Metrics Contract Services as being part of the Mayne Pharma global family, according to a company press release.

“We know from market research that Metrics enjoys a great deal of positive brand equity with clients, who associate us with attributes such as quality, reliability, responsiveness and honesty,” said John S. Ross, executive vice president in the press release. “The new Metrics Contract Services brand identity conveys that we’re the same people, delivering the same quality experiences for clients -- and that now we’re backed by a global pharmaceutical organization with the added resources to deliver even more capabilities.”

With its more descriptive suffix, the name Metrics Contract Services better communicates an ability to deliver a full range of outsourced pharmaceutical formulation development and manufacturing capabilities, Ross said. The new logo--an adaptation of Mayne Pharma’s logo--reflects that Metrics Contract Services is a key component of the global pharmaceutical company, the company reports.

Source: Metrics Contract Services

Articles in this issue

bp0714supply250-850754-1416902153096.jpg
Acute Need for Supply Chain Transparency
Metrics Contract Services Adopts New Name and Logo
Steady Progress Toward Continuous Flow API Synthesis
Steady Progress Toward Continuous Flow API Synthesis
Miller_Jim-850752-1408515461925.jpg
When Payers Refuse to Cover New Drugs, CMOs Take a Hit
Catalent Issues Initial Public Offering
Moving Toward a Safer Supply Chain

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Related Content
Advertisement
High Angle Shot of a Working Desk of an Successful Person in Office with Cityscape Window View. | Image credit: © Gorodenkoff - stock.adobe.com
August 6th 2025

The Future of Pharma: Connected, Continuous, and Compliant

Mike Hennessy Jr.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
August 6th 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
gemstones using infrared spectroscopy | Image Credit: © poco_bw - stock.adobe.com
August 6th 2025

FDA Adopts Intact NMR to Advance Nanoemulsion Drug Quality Assessment

Patrick Lavery
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
August 6th 2025

Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain

Jill Murphy
Chemical molecular formula hormone serotonin. Silhouette of a man head. Connected lines with dots background. | Image Credit: © JEGAS RA - stock.adobe.com
August 6th 2025

Zenara Secures First Generic Sertraline Approval from FDA, Plus Six Months of Market Exclusivity

Patrick Lavery
Futuristic health tech. A smartwatch projects a holographic health dashboard, providing real-time body analytics and vital signs monitoring anytime, anywhere. | Image Credit: © woravut - stock.adobe.com
August 6th 2025

How FDA’s ISTAND Initiative Supports Innovative Tools in Drug Discovery and Development

Patrick Lavery
Related Content
Advertisement
High Angle Shot of a Working Desk of an Successful Person in Office with Cityscape Window View. | Image credit: © Gorodenkoff - stock.adobe.com
August 6th 2025

The Future of Pharma: Connected, Continuous, and Compliant

Mike Hennessy Jr.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
August 6th 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
gemstones using infrared spectroscopy | Image Credit: © poco_bw - stock.adobe.com
August 6th 2025

FDA Adopts Intact NMR to Advance Nanoemulsion Drug Quality Assessment

Patrick Lavery
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
August 6th 2025

Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain

Jill Murphy
Chemical molecular formula hormone serotonin. Silhouette of a man head. Connected lines with dots background. | Image Credit: © JEGAS RA - stock.adobe.com
August 6th 2025

Zenara Secures First Generic Sertraline Approval from FDA, Plus Six Months of Market Exclusivity

Patrick Lavery
Futuristic health tech. A smartwatch projects a holographic health dashboard, providing real-time body analytics and vital signs monitoring anytime, anywhere. | Image Credit: © woravut - stock.adobe.com
August 6th 2025

How FDA’s ISTAND Initiative Supports Innovative Tools in Drug Discovery and Development

Patrick Lavery
About Us
Advertise
Contact Us
Editorial Info
Editorial Advisory Board
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.